Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective

References

• Ludwin SK. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J. Neuropathol. Exp. Neurol.65, 305–318 (2006).
   PubMed Web of Science ®Google Scholar
• Prat A, Antel J. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol.18, 225–230 (2005).
   PubMed Web of Science ®Google Scholar
• Barkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain120, 2059–2069 (1997).
   PubMed Web of Science ®Google Scholar
• Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr. Opin. Neurol.15, 239–245 (2002).
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain128, 2705–2712 (2005).
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J. Neurol. Sci.245, 123–126 (2006).
   PubMed Web of Science ®Google Scholar
• Tofts PS (Ed.).Quantitative MRI of the Brain: Measuring Changes Caused by Disease. John Wiley & Sons, Inc., IN, USA (2003).
   Google Scholar
• van Waesberghe JH, Castelijns JA, Scheltens P et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn. Reson. Imaging15, 155–162 (1997).
   PubMed Web of Science ®Google Scholar
• van Waesberghe JH, Kamphorst W, De Groot CJ et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol.46, 747–754 (1999).
   PubMed Web of Science ®Google Scholar
• Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann. Neurol.56, 407–415 (2004).
   PubMed Web of Science ®Google Scholar
• Filippi M, Campi A, Dousset V et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology45, 478–482 (1995).
   PubMed Web of Science ®Google Scholar
• Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology196, 511–515 (1995).
   PubMed Web of Science ®Google Scholar
• Catalaa I, Grossman RI, Kolson DL et al. Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter. Radiology216, 351–355 (2000).
   PubMed Web of Science ®Google Scholar
• Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry70, 311–317 (2001).
   PubMed Web of Science ®Google Scholar
• Dehmeshki J, Chard DT, Leary SM et al. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J. Neurol.250, 67–74 (2003).
   PubMed Web of Science ®Google Scholar
• Ge Y, Grossman RI, Udupa JK, Babb JS, Mannon LJ, McGowan JC. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J. Comput. Assist. Tomogr.26, 62–68 (2002).
   PubMed Web of Science ®Google Scholar
• Allen IV, McQuaid S, Mirakhur M, Nevin G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol. Sci.22, 141–144 (2001).
   PubMed Web of Science ®Google Scholar
• Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann. Neurol.47, 391–395 (2000).
   PubMed Web of Science ®Google Scholar
• Kornek B, Storch MK, Weissert R et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol.157, 267–276 (2000).
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med.338, 278–285 (1998).
   PubMed Web of Science ®Google Scholar
• Fazekas F, Ropele S, Enzinger C, Seifert T, Strasser-Fuchs S. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult. Scler.8, 479–484 (2002).
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol.43, 809–814 (1998).
   PubMed Web of Science ®Google Scholar
• Goodkin DE, Rooney WD, Sloan R et al. A serial study of new MS lesions and the white matter from which they arise. Neurology51, 1689–1697 (1998).
   PubMed Web of Science ®Google Scholar
• Pike GB, de Stefano N, Narayanan S et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology215, 824–830 (2000).
   PubMed Web of Science ®Google Scholar
• Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn. Reson. Med.29, 759–766 (1993).
   PubMed Web of Science ®Google Scholar
• Pike GB. Pulsed magnetization transfer contrast in gradient echo imaging: a two-pool analytic description of signal response. Magn. Reson. Med.36, 95–103 (1996).
   PubMed Web of Science ®Google Scholar
• Ropele S, Strasser-Fuchs S, Augustin M et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing–remitting multiple sclerosis. AJNR Am. J. Neuroradiol.21, 1885–1891 (2000).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Bozzali M, Iannucci G et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch. Neurol.59, 1406–1412 (2002).
   PubMedGoogle Scholar
• Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI. J. Neurol.249, 875–883 (2002).
   PubMed Web of Science ®Google Scholar
• Filippi M, Iannucci G, Cercignani M, Assunta RM, Pratesi A, Comi G. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch. Neurol.57, 1017–1021 (2000).
   PubMedGoogle Scholar
• Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology52, 1626–1632 (1999).
   PubMed Web of Science ®Google Scholar
• Ciccarelli O, Werring DJ, Wheeler-Kingshott CA et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology56, 926–933 (2001).
   PubMed Web of Science ®Google Scholar
• Vrenken H, Pouwels PJW, Geurts JJG et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J. Magn. Reson. Imaging23, 628–636 (2006).
   PubMed Web of Science ®Google Scholar
• Griffin CM, Parker GJ, Barker GJ, Thompson AJ, Miller DH. MTR and T1 provide complementary information in MS NAWM, but not in lesions. Mult. Scler.6, 327–331 (2000).
   PubMed Web of Science ®Google Scholar
• Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J. Neurol.249, 1279–1286 (2002).
   PubMed Web of Science ®Google Scholar
• Vaithianathar L, Tench CR, Morgan PS, Lin X, Blumhardt LD. White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J. Neurol. Sci.197, 45–50 (2002).
   PubMed Web of Science ®Google Scholar
• van Walderveen MA, van Schijndel RA, Pouwels PJW, Polman CH, Barkhof F. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J. Magn. Reson. Imaging18, 656–664 (2003).
   PubMed Web of Science ®Google Scholar
• Vrenken H, Geurts JJG, Knol DL et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology240, 811–820 (2006).
   PubMed Web of Science ®Google Scholar
• Vrenken H, Rombouts SA, Pouwels PJW, Barkhof F. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am. J. Neuroradiol.27, 868–874 (2006).
   PubMed Web of Science ®Google Scholar
• MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med.31, 673–677 (1994).
   PubMed Web of Science ®Google Scholar
• MacKay A, Laule C, Vavasour I, Bjarnason T, Kolind S, Madler B. Insights into brain microstructure from the T2 distribution. Magn. Reson. Imaging24, 515–525 (2006).
   PubMed Web of Science ®Google Scholar
• de Stefano N, Narayanan S, Francis GS et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol.58, 65–70 (2001).
   PubMed Web of Science ®Google Scholar
• Fu L, Matthews PM, de Stefano N et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain121, 103–113 (1998).
   PubMed Web of Science ®Google Scholar
• Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev.13, 23–31 (1989).
   PubMed Web of Science ®Google Scholar
• Chard DT, Griffin CM, McLean MA et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain125, 2342–2352 (2002).
   PubMed Web of Science ®Google Scholar
• Leary SM, Davie CA, Parker GJ et al.1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J. Neurol.246, 1023–1026 (1999).
   PubMed Web of Science ®Google Scholar
• Suhy J, Rooney WD, Goodkin DE et al.1H MRSI comparison of white matter and lesions in primary progressive and relapsing–remitting MS. Mult. Scler.6, 148–155 (2000).
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Presciutti O, Pelliccioli GP et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain122, 513–521 (1999).
   PubMed Web of Science ®Google Scholar
• van Walderveen MA, Barkhof F, Pouwels PJW, van Schijndel RA, Polman CH, Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann. Neurol.46, 79–87 (1999).
   PubMed Web of Science ®Google Scholar
• Schubert F, Seifert F, Elster C et al. Serial 1H-MRS in relapsing–remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations. MAGMA14, 213–222 (2002).
   PubMedGoogle Scholar
• Helms G, Stawiarz L, Kivisakk P, Link H. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn. Reson. Med.43, 102–110 (2000).
   PubMed Web of Science ®Google Scholar
• Vrenken H, Barkhof F, Uitdehaag BM, Castelijns JA, Polman CH, Pouwels PJW. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn. Reson. Med.53, 256–266 (2005).
   PubMed Web of Science ®Google Scholar
• Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci.15, 289–298 (1993).
   PubMed Web of Science ®Google Scholar
• Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain123, 1845–1849 (2000).
   PubMed Web of Science ®Google Scholar
• Castriota-Scanderbeg A, Fasano F, Filippi M, Caltagirone C. T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing–remitting and secondary progressive multiple sclerosis. Mult. Scler.10, 556–561 (2004).
   PubMed Web of Science ®Google Scholar
• Vrenken H, Geurts JJG, Knol DL et al. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am. J. Neuroradiol.27, 2005–2011 (2006).
   PubMed Web of Science ®Google Scholar
• Simon JH, Zhang S, Laidlaw DH et al. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome. J. Magn. Reson. Imaging24, 983–988 (2006).
   PubMed Web of Science ®Google Scholar
• Mottershead JP, Schmierer K, Clemence M et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis – a post-mortem study of the spinal cord. J. Neurol.250, 1293–1301 (2003).
   PubMed Web of Science ®Google Scholar
• Dawson JW. The histology of multiple sclerosis. Trans. R. Soc. Edinb. Earth Sci.50, 517–740 (1916).
   Google Scholar
• Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol.50, 389–400 (2001).
   PubMed Web of Science ®Google Scholar
• Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult. Scler.9, 323–331 (2003).
   PubMed Web of Science ®Google Scholar
• Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol.62, 723–732 (2003).
   PubMed Web of Science ®Google Scholar
• Bo L, Geurts JJG, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch. Neurol.64, 76–80 (2007).
   PubMedGoogle Scholar
• Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry25, 315–320 (1962).
   PubMed Web of Science ®Google Scholar
• Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain122, 17–26 (1999).
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Bo L, Pouwels PJW, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am. J. Neuroradiol.26, 572–577 (2005).
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol.50, 121–127 (2001).
   PubMed Web of Science ®Google Scholar
• Moriarty DM, Blackshaw AJ, Talbot PR et al. Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. AJNR Am. J. Neuroradiol.20, 1956–1962 (1999).
   PubMed Web of Science ®Google Scholar
• Lazeron RH, Langdon DW, Filippi M et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. Mult. Scler.6, 280–285 (2000).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Filippi M, Minicucci L et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am. J. Neuroradiol.21, 402–408 (2000).
   PubMed Web of Science ®Google Scholar
• Sokic DV, Stojsavljevic N, Drulovic J et al. Seizures in multiple sclerosis. Epilepsia42, 72–79 (2001).
   PubMed Web of Science ®Google Scholar
• Feinstein A, Roy P, Lobaugh N, Feinstein K, O’Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology62, 586–590 (2004).
   PubMed Web of Science ®Google Scholar
• Dalton CM, Chard DT, Davies GR et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain127, 1101–1107 (2004).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Zivadinov R, Carone DA et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am. J. Neuroradiol.26, 1824–1831 (2005).
   PubMed Web of Science ®Google Scholar
• de Stefano N, Matthews PM, Filippi M et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology60, 1157–1162 (2003).
   PubMed Web of Science ®Google Scholar
• Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage23, 1168–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Sailer M, Fischl B, Salat D et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain126, 1734–1744 (2003).
   PubMed Web of Science ®Google Scholar
• Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage34(2), 509–517 (2007).
   PubMed Web of Science ®Google Scholar
• Bozzali M, Cercignani M, Sormani MP, Comi G, Filippi M. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am. J. Neuroradiol.23, 985–988 (2002).
   PubMed Web of Science ®Google Scholar
• Ge Y, Grossman RI, Udupa JK, Babb JS, Kolson DL, McGowan JC. Magnetization transfer ratio histogram analysis of gray matter in relapsing–remitting multiple sclerosis. AJNR Am. J. Neuroradiol.22, 470–475 (2001).
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Reuling IE, Vrenken H et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn. Reson. Med.55, 478–483 (2006).
   PubMed Web of Science ®Google Scholar
• Davies GR, Ramio-Torrenta L, Hadjiprocopis A et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing–remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry75, 998–1002 (2004).
   PubMed Web of Science ®Google Scholar
• Rocca MA, Mezzapesa DM, Ghezzi A et al. A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. AJNR Am. J. Neuroradiol.26, 1136–1139 (2005).
   PubMed Web of Science ®Google Scholar
• Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain129, 2620–2627 (2006).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Judica E, Gallo A et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain129, 2628–2634 (2006).
   PubMed Web of Science ®Google Scholar
• Audoin B, Ibarrola D, Ranjeva JP et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum. Brain Mapp.20, 51–58 (2003).
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J. Neurol.252(Suppl. 5), V16–V24 (2005).
   PubMed Web of Science ®Google Scholar
• Lee M, Reddy H, Johansen-Berg H et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann. Neurol.47, 606–613 (2000).
   PubMed Web of Science ®Google Scholar
• Rocca MA, Mezzapesa DM, Falini A et al. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage18, 847–855 (2003).
   PubMed Web of Science ®Google Scholar
• Hellwig B. How the myelin picture of the human cerebral cortex can be computed from cytoarchitectural data. A bridge between von Economo and Vogt. J. Hirnforsch.34, 387–402 (1993).
   PubMedGoogle Scholar
• Brink BP, Veerhuis R, Breij EC, van der Valk P, Dijkstra CD, Bo L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J. Neuropathol. Exp. Neurol.64, 147–155 (2005).
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Pouwels PJW, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology236, 254–260 (2005).
   PubMed Web of Science ®Google Scholar
• Bedell BJ, Narayana PA. Implementation and evaluation of a new pulse sequence for rapid acquisition of double inversion recovery images for simultaneous suppression of white matter and CSF. J. Magn. Reson. Imaging8, 544–547 (1998).
   PubMed Web of Science ®Google Scholar
• Mugler JP 3rd, Bao S, Mulkern RV et al. Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology216, 891–899 (2000).
   PubMed Web of Science ®Google Scholar
• Pouwels PJW, Kuijer JP, Mugler JP III, Guttmann CR, Barkhof F. Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatial-resolution MR imaging. Radiology241, 873–879 (2006).
   PubMed Web of Science ®Google Scholar